Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 28, 2023

Graviti Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for GRAVITI PHARMS, and what generic and branded alternatives to GRAVITI PHARMS drugs are available?

GRAVITI PHARMS has eighteen approved drugs.

Summary for Graviti Pharms

US Patents:	0
Tradenames:	15
Ingredients:	15
NDAs:	18

Drugs and US Patents for Graviti Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Graviti Pharms	BUPROPION HYDROCHLORIDE	bupropion hydrochloride	TABLET, EXTENDED RELEASE;ORAL	211020-002	Jan 28, 2019	AB3	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Graviti Pharms	ATORVASTATIN CALCIUM	atorvastatin calcium	TABLET;ORAL	209912-002	Jun 18, 2018	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Graviti Pharms	MONTELUKAST SODIUM	montelukast sodium	TABLET;ORAL	209012-001	Apr 24, 2017	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Graviti Pharms	GABAPENTIN	gabapentin	CAPSULE;ORAL	207099-001	Mar 24, 2017	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Graviti Pharms

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys

McKesson

Medtronic

Colorcon

Express Scripts

AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.